EXAS vs NJR · rev $2.76B vs P/E 16, rev $1.35B
EXACT Sciences Corporation (EXAS) versus NewJersey Resources Corporation (NJR) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
NewJersey Resources Corporation (NJR) is a utilities - regulated gas company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported NJR revenue for 2025-09-30 was $1.35B. Net income was $335.6M. NJR currently screens at market cap $5.58B and trailing P/E 16.4.
EXAS currently screens at market cap $20.03B. NJR currently screens at market cap $5.58B and trailing P/E 16.4.
Not investment advice. Open the EXAS and NJR stock pages for the full models.
Not investment advice.